Imagine if, in a year’s time, 300m doses of a safe and effective Covid-19 vaccine have been manufactured in Donald Trump’s America, Xi Jinping’s China or Boris Johnson’s Britain. Who is going to get them? What are the chances that a nurse in India, or a doctor in Brazil, let alone a bus driver in Nigeria or a diabetic in Tanzania, will be given priority? The answer must be virtually nil.
想像一下，如果在一年內，唐納•川普(Donald Trump)領導的美國、習近平領導的中國或鮑里斯•強森(Boris Johnson)領導的英國生產出了3億劑安全有效的新型冠狀病毒肺炎（COVID-19，即2019冠狀病毒病）疫苗，誰會得到它們？印度的護士、巴西的醫生，更不用說奈及利亞的巴士司機或坦尚尼亞的糖尿病患者，這些人能優先接種疫苗的可能性有多大？答案一定幾乎爲零。
您已閱讀9%（581字），剩餘91%（5936字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。